expect sale ep
histor perform last quarter ep quarter averag
day earn move averag move averag move
rel nervous investor come expect around mdt earn releas thought print
solid overal organ revenu came bp estim highlight extrem strong diabet
growth coronari structur come driven tavr doubl digit growth pain therapi recal consent
decre languag chang better expect uptak brain therapi spine growth posit territori
overal mitg mid singl turn margin came gener in-lin consensu om came
slightli in-lin note fx hedg headwind major drag came bp
estim tax also came higher cost turn guid thought organ top-line
ep gener in-lin expect gotten number question impact recent
fx movement in-lin guid provid relief investor would expect share react posit
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect object
report investor consid report singl factor make invest decis
cardiac vascular group
note valu mm except per share data consensu estim base factset
posit organ sale growth guid also isi
estim
neg hf sale growth vs isi estim
growth driven lsd growth arrhythmia manag
heart failur low singl digit
servic solut hsd
posit coronari structur heart sale growth vs isi estim
posit diabet driven intens insulin manag dd diabet servic solut
ldd non-intens diabet therapi low twenti
posit rtg evrisi
posit mitg evrisi
posit fy free bn compar basi downward adjust
compani data evercor isi growth rate organ basi unless otherwis state
valuat methodolog base mix discount cash flow analysi rel valuat multipl
risk valuat includ regulatori risk overal market risk well unforeseen event relat individu cover
compani broader sector includ new competit product technolog
articl articl
time dissemin may et
analyst vijay kumar primarili respons prepar research report attest follow view opinion
render research report reflect person view subject compani issuer part research
analyst compens directli relat specif recommend view research report
